Variant report
Variant | nsv818763 |
---|---|
Chromosome Location | chr10:56239430-56273600 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:25)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:25 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr10:56255412-56255696 | A549 | lung: | n/a | chr10:56255576-56255587 |
2 | CEBPB | chr10:56255402-56255747 | HepG2 | liver: | n/a | chr10:56255576-56255587 |
3 | CTCF | chr10:56245983-56245998 | Spleen_OC | spleen: | n/a | n/a |
4 | E2F4 | chr10:56271686-56271852 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | EBF1 | chr10:56268927-56269162 | GM12878 | blood: | n/a | chr10:56269070-56269081 |
6 | EBF1 | chr10:56243914-56244319 | GM12878 | blood: | n/a | chr10:56244093-56244103 chr10:56244093-56244102 |
7 | ELK1 | chr10:56243977-56243990 | GM12878 | blood: | n/a | n/a |
8 | EP300 | chr10:56251301-56251319 | Hela-S3 | cervix: | n/a | n/a |
9 | GATA3 | chr10:56261680-56262139 | MCF-7 | breast: | n/a | n/a |
10 | GATA3 | chr10:56251982-56252054 | SH-SY5Y | brain: | n/a | n/a |
11 | JUN | chr10:56254353-56254502 | K562 | blood: | n/a | n/a |
12 | MAFK | chr10:56247535-56247784 | Hela-S3 | cervix: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
13 | MAFK | chr10:56247545-56247825 | IMR90 | lung: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
14 | MAFK | chr10:56247516-56247828 | HepG2 | liver: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
15 | MAFK | chr10:56247569-56247774 | K562 | blood: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
16 | MAFK | chr10:56247544-56247782 | HepG2 | liver: | n/a | chr10:56247675-56247686 chr10:56247674-56247689 chr10:56247675-56247686 |
17 | MYC | chr10:56250759-56250801 | K562 | blood: | n/a | n/a |
18 | POLR2A | chr10:56252783-56252839 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr10:56267036-56267313 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr10:56263776-56263887 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr10:56256869-56256894 | A549 | lung: | n/a | n/a |
22 | SPI1 | chr10:56258568-56258869 | HL-60 | blood: | n/a | n/a |
23 | STAT3 | chr10:56266752-56267061 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | WRNIP1 | chr10:56269202-56269456 | GM12878 | blood: | n/a | n/a |
25 | ZNF143 | chr10:56246572-56246893 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:56255140..56257501-chr10:56263291..56266087,2 | K562 | blood: | |
2 | chr10:56255140..56257501-chr10:56263291..56266087,2 | K562 | blood: | |
3 | chr10:56242648..56244262-chr10:56246298..56248916,2 | MCF-7 | breast: | |
4 | chr10:56242648..56244262-chr10:56246298..56248916,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MTRNR2L5-4 | chr10:56245990-56246076 | NONHSAT013457 |
2 | lnc-MTRNR2L5-4 | chr10:56245990-56246076 | ENSG00000234173.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234173 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4375355 | chr10:56240052-56240053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs377130114 | chr10:56240064-56240065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs545274186 | chr10:56240077-56240078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1342307 | chr10:56240104-56240105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530637341 | chr10:56240123-56240124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544357523 | chr10:56240127-56240128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560940525 | chr10:56240169-56240170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182530979 | chr10:56240174-56240175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74136156 | chr10:56243620-56243621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188664894 | chr10:56243629-56243630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534610177 | chr10:56243640-56243641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558125479 | chr10:56243646-56243647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146859249 | chr10:56243647-56243648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537246494 | chr10:56243679-56243680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557167471 | chr10:56243722-56243723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116854601 | chr10:56243747-56243748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541995514 | chr10:56243834-56243835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562192281 | chr10:56243862-56243863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564948227 | chr10:56243870-56243871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73255957 | chr10:56243907-56243908 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs577731834 | chr10:56243939-56243940 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs564446033 | chr10:56243949-56243950 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs373739231 | chr10:56243978-56243979 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs181479554 | chr10:56244032-56244033 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs552453883 | chr10:56244045-56244046 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs549984463 | chr10:56244050-56244051 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs376655856 | chr10:56244051-56244052 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs2104891 | chr10:56244067-56244068 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs112670573 | chr10:56244090-56244091 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs186018036 | chr10:56244097-56244098 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs375624334 | chr10:56244112-56244113 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs565759753 | chr10:56244180-56244181 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs529935326 | chr10:56244189-56244190 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs12771238 | chr10:56244223-56244224 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs140547696 | chr10:56244268-56244269 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs150489783 | chr10:56244276-56244277 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs12243412 | chr10:56244288-56244289 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs537311233 | chr10:56244331-56244332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs972789 | chr10:56244398-56244399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138280543 | chr10:56244401-56244402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537165005 | chr10:56244418-56244419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111599206 | chr10:56244445-56244446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149211649 | chr10:56244451-56244452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113740008 | chr10:56244496-56244497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572459539 | chr10:56244499-56244500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539960077 | chr10:56244542-56244543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11004334 | chr10:56244581-56244582 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs372841271 | chr10:56244604-56244605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559768076 | chr10:56244612-56244613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557641683 | chr10:56244627-56244628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Melanoma | 17363583 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56240000-56240200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr10:56243600-56244200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr10:56244200-56245400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr10:56245800-56246000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr10:56256600-56257000 | Enhancers | Spleen | Spleen |
6 | chr10:56262000-56262400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |